MX2015009914A - Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto. - Google Patents

Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.

Info

Publication number
MX2015009914A
MX2015009914A MX2015009914A MX2015009914A MX2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A
Authority
MX
Mexico
Prior art keywords
contact pathway
blood collection
collection devices
inhibitor
devices containing
Prior art date
Application number
MX2015009914A
Other languages
English (en)
Inventor
Keith A Moskowitz
Frank L Sinquett
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of MX2015009914A publication Critical patent/MX2015009914A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0263—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021—Test tubes specially adapted for centrifugation purposes
    • B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/042—Caps; Plugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Clinical Laboratory Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Se dan a conocer dispositivos para la recogida de sangre que contienen un anticoagulante y un aditivo que retrasa la coagulación mediante la inhibición de la vía de contacto para la generación de trombina. El aditivo es un aditivo del inhibidor de la vía de coagulación de contacto que es al menos uno de un inhibidor del Factor XI, un inhibidor del Factor XII, un inhibidor de la calicreína y combinaciones de los mismos, cada uno en una cantidad eficaz para mediar o suprimir la vía de contacto para la generación de trombina. Se proporcionan también, métodos de fabricación y uso de los dispositivos y de los kits que contienen los dispositivos.
MX2015009914A 2013-02-01 2014-01-31 Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto. MX2015009914A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361759742P 2013-02-01 2013-02-01
PCT/US2014/014089 WO2014121041A1 (en) 2013-02-01 2014-01-31 Blood collection devices containing contact pathway inhibition additives

Publications (1)

Publication Number Publication Date
MX2015009914A true MX2015009914A (es) 2015-09-25

Family

ID=51259520

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009914A MX2015009914A (es) 2013-02-01 2014-01-31 Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.

Country Status (12)

Country Link
US (1) US20140220552A1 (es)
EP (1) EP2950718A4 (es)
JP (1) JP2016505159A (es)
KR (1) KR20150141940A (es)
CN (1) CN105188535A (es)
AU (1) AU2014212194A1 (es)
BR (1) BR112015018077A2 (es)
CA (1) CA2899594A1 (es)
MX (1) MX2015009914A (es)
RU (1) RU2015136025A (es)
SG (1) SG11201505978PA (es)
WO (1) WO2014121041A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102523810B1 (ko) 2013-01-20 2023-04-21 다케다 파머수티컬 컴패니 리미티드 브래디키닌 매개 장애의 평가 및 치료
KR102521947B1 (ko) 2013-10-21 2023-04-14 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법
EP3294133B1 (en) * 2015-05-14 2019-09-04 General Electric Company Method and kit for separation and collection of plasma
CN116196995A (zh) 2015-08-13 2023-06-02 武田药品工业株式会社 用于评估接触系统激活的含有蛋白酶抑制剂的真空采血管
AU2016340826C1 (en) * 2015-10-19 2023-05-04 Takeda Pharmaceutical Company Limited Immunoassay to detect cleaved high molecular weight kininogen
JP6844890B2 (ja) * 2016-01-07 2021-03-17 藤森工業株式会社 採血管、試薬及びそれらを利用した血液性状分析方法
CN108342381A (zh) * 2017-01-24 2018-07-31 梁建国 一种用于稳定保存外周血中循环游离dna的溶剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403381B1 (en) * 1998-06-08 2002-06-11 University Of Vermont And State Agriculture College Inhibition of coagulation in blood and blood products
US20030064414A1 (en) * 2001-03-30 2003-04-03 Benecky Michael J. Rapid assessment of coagulation activity in whole blood
US7309468B2 (en) * 2002-05-13 2007-12-18 Becton, Dickinson And Company Protease inhibitor sample collection system
WO2004073864A2 (en) * 2003-02-13 2004-09-02 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
WO2005017486A2 (en) * 2003-06-09 2005-02-24 Mann Kenneth G A global test of the hemostatic system
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
DK2222707T3 (en) * 2007-11-21 2016-04-11 Univ Oregon Health & Science Monoclonal anti-factor XI antibodies and method of use thereof
CN103384496B (zh) * 2010-12-02 2016-10-12 贝克顿·迪金森公司 含有血液稳定剂的血液收集装置
CA2829037C (en) * 2011-03-09 2022-05-17 Csl Behring Gmbh Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces

Also Published As

Publication number Publication date
JP2016505159A (ja) 2016-02-18
BR112015018077A2 (pt) 2017-07-18
WO2014121041A1 (en) 2014-08-07
EP2950718A1 (en) 2015-12-09
SG11201505978PA (en) 2015-08-28
US20140220552A1 (en) 2014-08-07
AU2014212194A1 (en) 2015-09-17
RU2015136025A (ru) 2017-03-06
CN105188535A (zh) 2015-12-23
CA2899594A1 (en) 2014-08-07
EP2950718A4 (en) 2016-09-21
KR20150141940A (ko) 2015-12-21

Similar Documents

Publication Publication Date Title
MX2015009914A (es) Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
PH12016500676A1 (en) Pyrimidine fgfr4 inhibitors
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
GEP20197009B (en) 4'-substituted nucleosidederivatives as hiv reverse transcriptase inhibitors
EA201790202A1 (ru) Фталазиноны и изохинолиноны в качестве ингибиторов rock
WO2014194117A3 (en) Novel metalloproteases
AU2015208932A8 (en) (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors
UY34004A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO[2,3-d]PIRIMIDINA TROPOMIOSINA
PH12015502141A1 (en) Substituted xanthines and methods of use thereof
UY33958A (es) Inhibidores de la glucosilceramida sintasa
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
UY34045A (es) Derivados de imidazopiridina como inhibidores de pi3k
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
UY33930A (es) Inhibidores novedosos de quinasas
EP2547355A4 (en) TFPI HEMMER AND USE METHOD THEREFOR
UA117032C2 (uk) Селективний інгібітор фосфатидилінозитол-3-кінази-гамма
EA201591628A1 (ru) Дейтерированный палбоциклиб
EA201691177A1 (ru) Ингибиторы серин/треонинкиназ
MX2015011110A (es) Composiciones solidas que comprenden un activador de glucoquinasa y metodos para elaborar y utilizar las mismas.
MX366765B (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerósis múltiple.
PH12014502082A1 (en) Liquid tobacco compositions
CY1117414T1 (el) Παραγοντες αναστροφης αντιπηκτικου
WO2014175929A3 (en) Compositions and methods for amelioration of chronic renal failure and related symptoms in domestic animals
EA201490638A1 (ru) КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ РАКА C ПРИМЕНЕНИЕМ ИНГИБИТОРА PI3Kβ И ИНГИБИТОРА СИГНАЛЬНОГО ПУТИ MAPK, ВКЛЮЧАЯ MEK И RAF ИНГИБИТОРЫ